| Gene symbol | GPC3 | Synonyms | DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq26.2 | dbXrefs | |
| Description | glypican 3 | ||||
| GTO ID | GTC2842 |
| Trial ID | NCT05120271 |
| Disease | Merkel Cell Carcinoma | Squamous Cell Carcinoma | Hepatocellular Carcinoma | Myxoid Liposarcoma |
| Altered gene | GPC3 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BOXR1030 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors |
| Year | 2021 |
| Country | United States |
| Company sponsor | SOTIO, LLC |
| Other ID(s) | B1030-101 |
| Cohort 1 | |||||||||||
|
|||||||||||